Since the RPE cell dysfunction is involved in the early stages of the DR damage and miR-126 represents a promising target for novel antiangiogenic therapies, this study is aimed at investigating whether hyperglycemia affects expression of miR-126 and characterizing the molecular mechanisms through which miR-126 regulates VEGF-A expression in RPE cells. The gene discussed is VEGFA; the disease is Hyperglycemia.